Filter posts

Nautilus v. Biosig, Baxter v. Fresenius and Limelight v. Akamai

BIO weighed in on three Supreme Court cases in the last few months whose outcome …

Special 301: BIO Highlights Challenges in India

BIO recently testified before the U.S. government on the intellectual property challenges our members face …

Report Shows World's Weakest IP Environments

There is clear link between a country’s rate of economic development and the strength of …

Innovation Act Passed By House

The Innovation Act (H.R. 3309), which is intended to reduce frivolous patent-related litigation, was passed …

Innovation Act Threatens Biotech Innovation

BIO has grave concerns regarding the Innovation Act (H.R. 3309), as reported by the House Judiciary Committee. …

TRIPs Has Delivered: Patent Agreement Increases Drug Development

The TRIPs (Trade Related Aspects of Intellectual Property) Agreement, effective in 1996, has resulted in …

Patents Improve Public Health: Progressive Economy Reviews TRIPS at 20 Years

Progressive Economy released a research paper examining the effect of TRIPS (Trade-Related Aspects of Intellectual …

Neglected Diseases: What if IP was the Cure?

The Lancet Global Health Journal recently published an article “The drug and vaccine landscape for …

South Africa National Policy on Intellectual Property: Inconsistent with Biotech Development Goals

BIO submitted comments this week to the government of South Africa on their proposed “Draft …

New Bill Calls for No WTO-Plus Benefits for Countries that Violate IP

A new Bill in the U.S. House of Representatives seeks to remove WTO-plus trade benefits …